Stocksigma LogoStocksigma Logo

Novelix Pharmaceuticals Reports Strong Q2 FY27 Results with Net Profit Surging 193% YoY

Novelix Pharmaceuticals posted standalone revenue from operations of ₹4,473.12 lakhs for the quarter ended 30th Sep'26, up 23.03% YoY from ₹3,635.89 lakhs

Novelix Pharmaceuticals Reports Strong Q2 FY27 Results with Net Profit Surging 193% YoY

Novelix Pharmaceuticals Ltd · Financial Result · 12 Nov 2026, 12:57 am

Novelix Pharmaceuticals Reports Strong Q2 FY27 Results with Net Profit Surging 193% YoY Novelix Pharmaceuticals posted standalone revenue from operations of ₹4,473.12 lakhs for the quarter ended 30th Sep'26, up 23.03% YoY from ₹3,635.89 lakhs and 21.18% QoQ from ₹3,691.39 lakhs. Net profit rose 193.23% YoY and 32.60% QoQ to ₹156.32 lakhs, compared to ₹53.31 lakhs in Q2 FY26. PBT surged to ₹186.62 lakhs versus ₹71.89 lakhs YoY. Basic and diluted EPS improved to ₹0.57 from ₹0.37 YoY. For H1 FY27, revenue reached ₹8,164.51 lakhs with net profit of ₹274.21 lakhs.

Original exchange filing (PDF)

More announcements from Novelix Pharmaceuticals Ltd

All Novelix Pharmaceuticals Ltd announcements